JP2024534786A5 - - Google Patents
Info
- Publication number
- JP2024534786A5 JP2024534786A5 JP2024509092A JP2024509092A JP2024534786A5 JP 2024534786 A5 JP2024534786 A5 JP 2024534786A5 JP 2024509092 A JP2024509092 A JP 2024509092A JP 2024509092 A JP2024509092 A JP 2024509092A JP 2024534786 A5 JP2024534786 A5 JP 2024534786A5
- Authority
- JP
- Japan
- Prior art keywords
- poly
- nucleic acid
- acid sequence
- antigen
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163233570P | 2021-08-16 | 2021-08-16 | |
| US63/233,570 | 2021-08-16 | ||
| US202163286952P | 2021-12-07 | 2021-12-07 | |
| US63/286,952 | 2021-12-07 | ||
| PCT/US2022/040317 WO2023022973A2 (en) | 2021-08-16 | 2022-08-15 | Compositions containing polynucleotide amphiphiles and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024534786A JP2024534786A (ja) | 2024-09-26 |
| JP2024534786A5 true JP2024534786A5 (cg-RX-API-DMAC7.html) | 2025-08-13 |
Family
ID=85240944
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024509092A Pending JP2024534786A (ja) | 2021-08-16 | 2022-08-15 | ポリヌクレオチド両親媒性物質を含有する組成物及びその使用方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20250134992A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4388102A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024534786A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022329730A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3228856A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023022973A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2026519945A (ja) * | 2023-04-26 | 2026-06-19 | エリシオ セラピューティクス, インク. | ポリヌクレオチド及びポリペプチド両親媒性物質を含有する組成物並びにその使用方法 |
| AU2024277363A1 (en) * | 2023-05-25 | 2025-12-11 | Elicio Therapeutics, Inc. | Compositions containing p53 peptide amphiphiles and methods of use thereof |
| JP2026518784A (ja) * | 2023-05-25 | 2026-06-09 | エリシオ セラピューティクス, インク. | Brafペプチド両親媒性物質を含有する組成物及びその使用方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004108937A1 (en) * | 2003-06-04 | 2004-12-16 | Bioleaders Corporation | Cell surface expression vector of sars virus antigen and microorganisms transformed thereby |
| JP5759678B2 (ja) * | 2010-04-14 | 2015-08-05 | 国立大学法人埼玉大学 | 核酸リンカー |
| US9200314B2 (en) * | 2010-07-21 | 2015-12-01 | Takara Bio Inc. | Synthetic siRNA detection method |
| CN112587671A (zh) * | 2012-07-18 | 2021-04-02 | 博笛生物科技有限公司 | 癌症的靶向免疫治疗 |
| US10093701B2 (en) * | 2012-09-07 | 2018-10-09 | University Of Miami | Fusion proteins for promoting an immune response, nucleic acids encoding same, and methods of making and use thereof |
| AU2014322046B2 (en) * | 2013-09-20 | 2021-02-04 | Daiichi Sankyo Company, Limited | Complex containing oligonucleotide having immunopotentiating activity and use thereof |
| EP3247328B1 (en) * | 2015-01-21 | 2026-01-07 | Genevant Sciences Gmbh | Methods, compositions, and systems for delivering therapeutic and diagnostic agents into cells |
| US12247052B2 (en) * | 2018-03-02 | 2025-03-11 | Elicio Therapeutics, Inc. | CpG amphiphiles and uses thereof |
| EP3801612A1 (en) * | 2018-05-29 | 2021-04-14 | The Provost, Fellows, Foundation Scholars, and the other members of Board, of the College of the Holy & Undiv. Trinity of Queen Elizabeth near Dublin | Vaccine adjuvants |
| JP2022525781A (ja) * | 2019-03-20 | 2022-05-19 | マサチューセッツ インスティテュート オブ テクノロジー | 免疫細胞療法における両親媒性物質の使用およびそのための組成物 |
-
2022
- 2022-08-15 WO PCT/US2022/040317 patent/WO2023022973A2/en not_active Ceased
- 2022-08-15 AU AU2022329730A patent/AU2022329730A1/en active Pending
- 2022-08-15 CA CA3228856A patent/CA3228856A1/en active Pending
- 2022-08-15 US US18/684,014 patent/US20250134992A1/en active Pending
- 2022-08-15 JP JP2024509092A patent/JP2024534786A/ja active Pending
- 2022-08-15 EP EP22858990.9A patent/EP4388102A4/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7625637B2 (ja) | B型肝炎ウイルス感染のためのRNAi薬 | |
| JP7763907B2 (ja) | B型肝炎ウイルス感染のためのRNAi薬 | |
| US7709449B2 (en) | Nucleic acid-based compounds and methods of use thereof | |
| CN111527207A (zh) | GalNAc衍生物 | |
| PT850300E (pt) | Metodo de modulacao da expressao de genes com resposta imunoestimulante reduzida | |
| CA2081777A1 (en) | Inhibition of influenza virus replication by oligonucleotides | |
| JP2006515277A5 (cg-RX-API-DMAC7.html) | ||
| JP2024532465A5 (cg-RX-API-DMAC7.html) | ||
| EP3758712B1 (en) | Cpg amphiphiles and uses thereof | |
| CN115252772A (zh) | 人工合成的含CpG单链脱氧寡核苷酸在疫苗中的应用 | |
| BR112015016420B1 (pt) | Composto de oligonucleotídeo imunorregulatório, composição farmacêutica e uso do composto iro ou da composição farmacêutica | |
| JP2024533371A5 (cg-RX-API-DMAC7.html) | ||
| JP2024529875A5 (cg-RX-API-DMAC7.html) | ||
| JP2023548205A5 (cg-RX-API-DMAC7.html) | ||
| JP2023528016A5 (cg-RX-API-DMAC7.html) | ||
| CN121620390A (zh) | 用于调节针对乙型肝炎病毒感染的免疫应答的寡核苷酸 | |
| TW202345861A (zh) | 經修飾之間隔體寡聚物及其使用方法 | |
| CN114127292A (zh) | 减轻反义核酸的毒性的方法 | |
| US12163132B2 (en) | Gapmer antisense oligonucleotides targeting SARS-CoV-2 for treating COVID 19 | |
| RU2006111336A (ru) | Р185-кодирующая днк и ее терапевтические применения | |
| RU2000121049A (ru) | Антигены neisseria meningitidis | |
| WO2024248367A1 (ko) | 단백질 고효율 발현용 mRNA 구조체 플랫폼 | |
| TW202604544A (zh) | 抑制CTGF基因表達的siRNA及其組合物 | |
| WO2026026811A1 (zh) | 一种具有双靶点基因抑制作用的核酸缀合物及其应用 | |
| HK40062579A (en) | Rnai agents for hepatitis b virus infection |